Clinical Trial: A prospective, single-arm, multicenter clinical study of a conditioning regimen containing cetipae and melphalan for the treatment of relapsed/refractory or MRD-positive acute myeloid leukemia (China)

China, Aug. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A prospective, single-arm, multicenter clinical study of a conditioning regimen containing cetipae and melphalan for the treatment of relapsed/refractory or MRD-positive acute myeloid leukemia'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130758

Registration Time: 2026/08/24

Type: Interventional study

Primary Sponsor: The First Affiliated Hospital of Zhengzhou University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=294152

Published by HT Digital Content Services with permission from Health Daily Digest....